Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomarin Pharmaceuticals
(NQ:
BMRN
)
80.76
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
80.76
Bid (Size)
78.01 (1)
Ask (Size)
87.65 (3)
Prev. Close
80.76
Today's Range
80.76 - 80.76
52wk Range
76.02 - 99.56
Shares Outstanding
183,352,255
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
April 30, 2024
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
Via
Chartmill
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
April 27, 2024
Opportunistic investors can still find bargains, even with the Nasdaq Composite up 49% since the start of 2023.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Performance
YTD
-17.63%
-17.63%
1 Month
-7.28%
-7.28%
3 Month
-9.89%
-9.89%
6 Month
-0.85%
-0.85%
1 Year
-16.73%
-16.73%
More News
Read More
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)
April 25, 2024
Via
Benzinga
Looking Into Biomarin Pharmaceutical's Recent Short Interest
April 03, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
April 25, 2024
Via
InvestorPlace
BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Misses Revenue for Q1 2024
April 24, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 24, 2024
Via
Benzinga
Don't overlook NASDAQ:BMRN—a stock with solid growth prospects and a reasonable valuation.
April 08, 2024
Via
Chartmill
While growth is established for NASDAQ:BMRN, the stock's valuation remains reasonable.
March 18, 2024
Via
Chartmill
The Latest Analyst Ratings For Biomarin Pharmaceutical
February 23, 2024
Via
Benzinga
Recap: Biomarin Pharmaceutical Q4 Earnings
February 22, 2024
Via
Benzinga
Decoding 8 Analyst Evaluations For Biomarin Pharmaceutical
January 30, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical
December 21, 2023
Via
Benzinga
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
March 16, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Investors seeking growth at a reasonable cost should explore NASDAQ:BMRN.
February 26, 2024
Via
Chartmill
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $200 Right Now
February 07, 2024
Via
The Motley Fool
4 Marvelous Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
January 20, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
January 10, 2024
Via
InvestorPlace
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
December 02, 2023
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
November 09, 2023
Via
InvestorPlace
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
Via
InvestorPlace
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake
November 07, 2023
Via
Investor's Business Daily
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
November 07, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.